Pharma Bro acknowledges 'fooling around' with MRNA short at $80 prior to its 177% surge after cancer vaccine trial results—‘I wager many individuals were let go.’

MRNA · Moderna Inc.

The AI's read

Moderna blew up after positive Phase 3 cancer vaccine data and the stock ripped ~177%, turning a written-off COVID story into an oncology breakout. Wall Street was caught flat-footed and volume exploded, so the move was fast and furious. The market already priced a huge chunk of the outcome — MRNA is up ~158.8% intraday with ~185 million shares trading and a market cap jump near $38B. That size of a move compresses near-term asymmetry and raises short-term reversal risk. We lean neutral. The catalyst is real and company-specific, but the upside looks largely front-loaded so any position must respect the massive move and need for follow-up data.